Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04191096 |
|---|---|
| Brief Title: | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991) |
| First Submitted : | December 5, 2019 |
| First Submitted that Met QC Criteria : | December 5, 2019 |
| First Posted : | December 9, 2019 |
| Last Update Submitted that Met QC Criteria : | July 6, 2021 |
| Last Update Posted : | July 7, 2021 |